Regulatory watch: Impact of scientific advice from the European Medicines Agency

Nature Reviews Drug Discovery

Volumn 14, Issue 5, 2015, Pages 302-303

  Hofer, Matthias P ^a   Jakobsson, Christina ^a   Zafiropoulos, Nikolaos ^a   Vamvakas, Spiros ^a   Vetter, Thorsten ^a   Regnstrom, Jan ^a   Hemmings, Robert J ^b  

^a EUROPEAN MEDICINES AGENCY   (United Kingdom)

^b MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DRUG APPROVAL; DRUG DEVELOPMENT; DRUG RESEARCH; EUROPEAN MEDICINES AGENCY; HEALTH CARE ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; PROTOCOL COMPLIANCE; QUALITY CONTROL; SHORT SURVEY; STUDY DESIGN; DRUG DESIGN; EUROPE; GOVERNMENT; HUMAN; LEGISLATION AND JURISPRUDENCE; PROCEDURES; RISK ASSESSMENT;

DRUG APPROVAL; DRUG DESIGN; EUROPE; GOVERNMENT AGENCIES; HUMANS; RISK ASSESSMENT;

EID: 84929025241     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4621     Document Type: Short Survey

References (0)